Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Opiant Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −1 vs. Q2 2022
- Shares held
- 1.81M
- −58.7K (−3.2%) vs. Q2 2022
- Total value
- $19.4M
- −$2.94M (−13.2%) vs. Q2 2022
- New holders
- 3
- 10 more added
- Sold out
- 4
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OPNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 37 | $43.2M |
| Q3 2022 | 32 | $19.4M |
| Q2 2022 | 33 | $22.3M |
| Q1 2022 | 41 | $33.3M |
| Q4 2021 | 42 | $47.6M |
| Q3 2021 | 35 | $32.7M |
| Q2 2021 | 26 | $11.8M |
| Q1 2021 | 31 | $9.70M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Opiant Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HealthInvest Partners AB | 210,000 | $2.26M | 4.77% | 00.0% | Unchanged |
| Wells Fargo & Company | 205,117 | $2.21M | 0.00% | +1,886+0.9% | Added |
| Apis Capital Advisors, LLC | 204,000 | $2.19M | 3.29% | +8,000+4.1% | Added |
| Vanguard Group Inc | 187,158 | $2.01M | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 176,915 | $1.90M | 0.00% | −16,500−8.5% | Reduced |
| Stonepine Capital Management, LLC | 152,278 | $1.64M | 0.74% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 126,978 | $1.36M | 0.01% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 112,492 | $1.21M | 0.00% | −14,800−11.6% | Reduced |
| Parkman Healthcare Partners LLC | 76,530 | $823.0K | 0.23% | +898+1.2% | Added |
| Geode Capital Management, LLC | 48,727 | $523.0K | 0.00% | +167+0.3% | Added |
| Essex Investment Management Co LLC | 47,169 | $507.0K | 0.08% | −3,236−6.4% | Reduced |
| BlackRock Inc. | 39,922 | $429.0K | 0.00% | +127+0.3% | Added |
| Northern Trust Corp | 38,924 | $418.0K | 0.00% | +1,498+4.0% | Added |
| Perritt Capital Management Inc | 30,500 | $328.0K | 0.21% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 23,400 | $252.0K | 0.00% | −51,000−68.5% | Reduced |
| Two Sigma Investments, LP | 21,730 | $234.0K | 0.00% | −15,326−41.4% | Reduced |
| Bank of New York Mellon Corp | 17,796 | $191.0K | 0.00% | +117+0.7% | Added |
| Mesirow Financial Investment Management, Inc. | 17,633 | $190.0K | 0.90% | +17,633 | New |
| Mariner, LLC | 13,550 | $146.0K | 0.00% | +13,550 | New |
| State Street Corp | 13,285 | $143.0K | 0.00% | 00.0% | Unchanged |
| Trexquant Investment LP | 13,219 | $142.0K | 0.00% | +1,000+8.2% | Added |
| Susquehanna Fundamental Investments, LLC | 10,052 | $108.0K | 0.00% | +10,052 | New |
| Morgan Stanley | 7,211 | $77.0K | 0.00% | −1,546−17.7% | Reduced |
| Advisor Group Holdings, Inc. | 5,800 | $62.0K | 0.00% | +300+5.5% | Added |
| UBS Group AG | 1,446 | $16.0K | 0.00% | +266+22.5% | Added |
| Royal Bank of Canada | 1,233 | $13.0K | 0.00% | −167−11.9% | Reduced |
| Lindbrook Capital, LLC | 500 | $5.00K | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 500 | $5.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 434 | $4.00K | 0.00% | −935−68.3% | Reduced |
| American Research & Management Co. | 300 | $3.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 180 | $1.94K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −10,044−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −384−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −266−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −20−100.0% | Sold out |